IP Library Granted Patent US 10,842,824
Granted Patent B2
US 10,842,824 · App. 16/039,765 · Granted Nov 24, 2020

Method for inducing angiogenesis

Inventor: Thomas J. Koob (Marietta, GA)
Assignee: MIMEDX GROUP, INC.
A61K35/50A61L27/3604A61L27/3804A61L27/54A61L2300/414A61L2400/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,842,824
App. No.
16/039,765
Granted
Nov 24, 2020
Kind
B2
Abstract

Disclosed herewith is a method for inducing angiogenesis using modified placental tissue or an extract thereof to treat conditions other than cardiovascular conditions.

Claims (12)

1. A method for inducing angiogenesis in a non-cardiovascular body region of a subject having diabetic peripheral neuropathy, said method comprising delivering an effective amount of a composition comprising modified placental tissue to said non-cardiovascular body region, wherein said modified placental tissue comprises an amnion layer having an epithelial layer which has not been substantially removed.

2. The method of claim 1 , wherein blood flow to the non-cardiovascular body region is restricted.

3. The method of claim 1 , wherein the non-cardiovascular body region includes peripheral portions of the body, liver, lung, nerve, bone, or skin.

4. The method of claim 3 , wherein the peripheral portions of the body are limbs, hands, or feet.

5. The method of claim 1 , wherein the modified placental tissue further comprises one or more of isolated chorion, intermediate layer, Wharton's jelly, isolated amniotic epithelial layer, or any combination thereof.

6. The method of claim 1 , wherein the modified placental tissue is a tissue graft.

7. The method of claim 1 , wherein the modified placental tissue is micronized.

8. The method of claim 1 , wherein the composition is injectable.

9. The method of claim 1 , wherein the composition is a liquid, gel, or paste.

10. The method of claim 1 , wherein the composition is administered by a nebulizer.

11. A method for inducing angiogenesis in a non-cardiovascular body region of a subject having diabetic peripheral neuropathy, which method comprises injecting an effective amount of an aqueous solution comprising micronized modified placental tissue to said non-cardiovascular body region and maintaining said region under conditions wherein angiogenesis is induced, wherein said modified placental tissue comprises an amnion layer having an epithelial layer which has not been substantially removed.

12. The method of claim 11 , wherein the non-cardiovascular body region includes peripheral portions of the body, liver, lung, nerve, bone, or skin.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2024
From: HAYFIN SERVICES LLP
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 066493/0322 →
SECURITY INTEREST Recorded Jan 25, 2024
From: MIMEDX GROUP, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 066371/0136 →
SECURITY INTEREST Recorded Jan 25, 2024
From: MIMEDX GROUP, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 066250/0132 →
RELEASE OF SECURITY INTEREST Recorded Jul 2, 2020
From: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 054075/0687 →
PATENT SECURITY AGREEMENT Recorded Jul 2, 2020
From: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
To: HAYFIN SERVICES LLP, AS COLLATERAL AGENT
Reel/Frame 053121/0833 →
SECURITY INTEREST Recorded Jun 11, 2019
From: MIMEDX GROUP, INC.
To: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 049426/0863 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2018
From: KOOB, THOMAS J.
To: MIMEDX GROUP, INC.
Reel/Frame 046447/0039 →
Continuity (3)
Continuation 14601075 · Jan 20, 2015
Provisional Application 61928986 · Jan 17, 2014
Related Publication 20190022146A1 · Jan 24, 2019